Form 4 for EW Edwards Lifesciences
Accepted 2023-03-08 00:00:00 ET · period of report 2023-03-08 · accession 0001225208-23-003597 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-03-08 | 2023-03-08 | EW | Lemercier Jean-Luc M | CVP, EMEACLA, JAPAC | S - Sale+OE | $76.95 | -6,640 | 168.9K | -4% | -$511.0K |
| D | 2023-03-08 | 2023-03-08 | EW | Lemercier Jean-Luc M | CVP, EMEACLA, JAPAC | M - OptEx | $35.20 | +6,640 | 175.5K | +4% | +$233.7K |
| D | 2023-03-08 | 2023-03-08 | EW | Lemercier Jean-Luc M | CVP, EMEACLA, JAPAC | M - OptEx | $0.00 | -6,640 | 13.3K | -33% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-03-08 | S | D | 50 | $77.43 | 175,464.87 | D | — | — | |
| 2 | Common | Common Stock | 2023-03-08 | S | D | 6,590 | $76.95 | 168,874.87 | D | — | — | (F2) This transaction was executed in multiple trades at prices ranging from $76.43 to $77.36 The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. |
| 3 | Common | Common Stock | 2023-03-08 | M | A | 6,640 | $35.20 | 175,514.87 | D | — | — | |
| 4 | Derivative | Employee Stock Option (Right to Acquire) | 2023-03-08 | M | D | 6,640 | $0.00 | 13,280 | D | $35.20 · 2017-05-12 to 2023-05-11 | 6,640 Common Stock |